Fig. 2From: Functional outcomes of extended-release methylphenidate and atomoxetine in children: retrospective chart analysisLine chart depicts the result of mixed-model repeated-measures analysis of ADHD symptom severity. †ATX atomoxetine, OROS-MPH osmotic-release oral delivery system methylphenidate, T-DSM-IV-S the Turgay DSM-IV disruptive behavior disorders rating scale, AIC Akaike information criterion. a Is total score, b is inattention score, and c is hyperactivity/impulsivity scoreBack to article page